Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05565937 · ClinicalTrials.gov registry record · NA

A Study to Evaluate the Safety and Effectiveness of a Contact Lens Cleaning and Disinfecting Solution

A NA study, sponsored by Bausch & Lomb Incorporated.

Completed
Registry status
NA
Development phase
295
Enrollment target

NCT05565937 is a NA study that has completed, run by Bausch & Lomb Incorporated. The registered enrollment target is 295 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05565937, a NA study, has completed, sponsored by Bausch & Lomb Incorporated.

COMPLETED
Registry status
NA
Development phase
295 participants
Enrollment target

Study Summary

Approximately 340 participants (680 eyes) will be enrolled in this three-month, two-arm, 1:1 randomized, parallel-group, bilateral, double-masked study at approximately 22 investigative sites in the United States. Participants will be required to wear dispensed study lenses on a daily wear basis for three months with scheduled in-office replacement of study lenses at the 1-Month and 2-Month Follow-Up Visits.

Interventions

  • DEVICE BL-3100-NBR03 multi-purpose solution
  • DEVICE renu® Advanced Formula multi-purpose solution

Trial Details

FieldValue
Enrollment Target 295 participants
Start Date 2023-04-12
Est. Completion 2024-02-28
Phase NA

Sponsor

Bausch & Lomb Incorporated

174 total trials

What the Registry Record Tells You About NCT05565937

The ClinicalTrials.gov registry entry for NCT05565937 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 295 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bausch & Lomb Incorporated, which has 174 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which BL-3100-NBR03 multi-purpose solution is the first listed.

NCT05565937 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT05565937 about?

NCT05565937 is a clinical study titled "A Study to Evaluate the Safety and Effectiveness of a Contact Lens Cleaning and Disinfecting Solution". Approximately 340 participants (680 eyes) will be enrolled in this three-month, two-arm, 1:1 randomized, parallel-group, bilateral, double-masked study at approximately 22 investigative sites in the United States. Participants will be required to wear dispensed study lenses on a daily wear basis for...

What is the current status of trial NCT05565937?

This trial is currently completed. It is a NA study. The enrollment target is 295 participants. The study started on 2023-04-12. Estimated completion is 2024-02-28.

What interventions are being tested in trial NCT05565937?

The interventions under investigation include: BL-3100-NBR03 multi-purpose solution (DEVICE), renu® Advanced Formula multi-purpose solution (DEVICE).

Who is sponsoring clinical trial NCT05565937?

This trial is sponsored by Bausch & Lomb Incorporated, which has 174 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.